| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AACR highlights advances and threats to US cancer research
|
Kirby, Tony
|
|
|
25 |
11 |
p. 1402
|
artikel
|
| 2 |
Abortion restrictions have a negative impact on cancer care
|
Devi, Sharmila
|
|
|
25 |
11 |
p. 1408
|
artikel
|
| 3 |
Access to diagnostic imaging and radiotherapy technologies for patients with cancer in the Baltic countries, eastern Europe, central Asia, and the Caucasus: a comprehensive analysis
|
Dosanjh, Manjit
|
|
|
25 |
11 |
p. 1487-1495
|
artikel
|
| 4 |
Approval of single-use e-cigarettes ban in France
|
Das, Manjulika
|
|
|
25 |
11 |
p. 1404
|
artikel
|
| 5 |
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
|
Bakas, Spyridon
|
|
|
25 |
11 |
p. e589-e601
|
artikel
|
| 6 |
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements
|
Villanueva-Meyer, Javier E
|
|
|
25 |
11 |
p. e581-e588
|
artikel
|
| 7 |
ASTRO 2024 Annual Meeting
|
Patodia, Smriti
|
|
|
25 |
11 |
p. 1405
|
artikel
|
| 8 |
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
|
Oliveira, Mafalda
|
|
|
25 |
11 |
p. 1424-1439
|
artikel
|
| 9 |
Cancer control in the Commonwealth: a roadmap
|
Atun, Rifat
|
|
|
25 |
11 |
p. 1409-1412
|
artikel
|
| 10 |
Caring for carers of people with cancer
|
The Lancet Oncology,
|
|
|
25 |
11 |
p. 1387
|
artikel
|
| 11 |
Celiac plexus radiosurgery for retroperitoneal pain syndrome
|
Senturk, Ertugrul
|
|
|
25 |
11 |
p. e527
|
artikel
|
| 12 |
Celiac plexus radiosurgery for retroperitoneal pain syndrome – Authors' reply
|
Lawrence, Yaacov R
|
|
|
25 |
11 |
p. e528
|
artikel
|
| 13 |
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma
|
Lin, Queran
|
|
|
25 |
11 |
p. e534
|
artikel
|
| 14 |
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma
|
Xiang, Ze
|
|
|
25 |
11 |
p. e535
|
artikel
|
| 15 |
Concerns regarding the AtTEnd trial in advanced endometrial carcinoma – Authors' reply
|
Biagioli, Elena
|
|
|
25 |
11 |
p. e536
|
artikel
|
| 16 |
Correction to Lancet Oncol 2024; 25: 1310–24
|
|
|
|
25 |
11 |
p. e542
|
artikel
|
| 17 |
Correction to Lancet Oncol 2024; 25: 1357–70
|
|
|
|
25 |
11 |
p. e542
|
artikel
|
| 18 |
Correction to Lancet Oncol 2024; 25: 1325–36
|
|
|
|
25 |
11 |
p. e542
|
artikel
|
| 19 |
Correction to Lancet Oncol 2024; 25: 1453–64
|
|
|
|
25 |
11 |
p. e542
|
artikel
|
| 20 |
Correction to Lancet Oncol 2024; 25: 1371–86
|
|
|
|
25 |
11 |
p. e542
|
artikel
|
| 21 |
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
|
Morice, Philippe
|
|
|
25 |
11 |
p. e602-e610
|
artikel
|
| 22 |
[18F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer
|
Xu, Xiaoling
|
|
|
25 |
11 |
p. e539
|
artikel
|
| 23 |
[18F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer
|
Bowen Jones, Sarah
|
|
|
25 |
11 |
p. e540
|
artikel
|
| 24 |
[18F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer – Authors' reply
|
Thureau, Sébastien
|
|
|
25 |
11 |
p. e541
|
artikel
|
| 25 |
Focus where it matters: turning insights into advocacy
|
Christodouleas, John
|
|
|
25 |
11 |
p. 1396-1397
|
artikel
|
| 26 |
Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis
|
Rumgay, Harriet
|
|
|
25 |
11 |
p. 1413-1423
|
artikel
|
| 27 |
Interchangeability of immune checkpoint inhibitors: an urgent need for action
|
Zietse, Michiel
|
|
|
25 |
11 |
p. e611-e616
|
artikel
|
| 28 |
Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data
|
Lund, Marie
|
|
|
25 |
11 |
p. 1496-1506
|
artikel
|
| 29 |
Jordan joins the Global Platform for Access to Childhood Cancer Medicines
|
Gourd, Elizabeth
|
|
|
25 |
11 |
p. 1403
|
artikel
|
| 30 |
Omitting study limitations might have implications for the patients
|
de Boissieu, Paul
|
|
|
25 |
11 |
p. e537
|
artikel
|
| 31 |
Omitting study limitations might have implications for the patients – Authors' reply
|
Blay, Jean-Yves
|
|
|
25 |
11 |
p. e538
|
artikel
|
| 32 |
Organisations withdraw from cancer conference over tobacco link
|
Wilkinson, Emma
|
|
|
25 |
11 |
p. 1400
|
artikel
|
| 33 |
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
|
D'Alessio, Antonio
|
|
|
25 |
11 |
p. 1465-1475
|
artikel
|
| 34 |
Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial
|
Provencio, Mariano
|
|
|
25 |
11 |
p. 1453-1464
|
artikel
|
| 35 |
President Biden taking Cancer Moonshot global
|
Devi, Sharmila
|
|
|
25 |
11 |
p. 1401
|
artikel
|
| 36 |
PSMA-PET research: addressing challenges and prospects
|
Shan, Dan
|
|
|
25 |
11 |
p. e532
|
artikel
|
| 37 |
PSMA-PET research: addressing challenges and prospects
|
Hu, Hantong
|
|
|
25 |
11 |
p. e531
|
artikel
|
| 38 |
PSMA-PET research: addressing challenges and prospects – Authors' reply
|
Hadaschik, Boris A
|
|
|
25 |
11 |
p. e533
|
artikel
|
| 39 |
Radiotherapy and conflict: from disruption to expansion and hope
|
Hammad, Nazik
|
|
|
25 |
11 |
p. 1397-1399
|
artikel
|
| 40 |
Radiotherapy and theranostics: a Lancet Oncology Commission
|
Abdel-Wahab, May
|
|
|
25 |
11 |
p. e545-e580
|
artikel
|
| 41 |
Radiotherapy and theranostics in a changing world
|
Lai, Cheryl
|
|
|
25 |
11 |
p. 1391-1392
|
artikel
|
| 42 |
Radiotherapy gaps and new frontiers in the Commonwealth
|
Yap, Mei Ling
|
|
|
25 |
11 |
p. 1394-1396
|
artikel
|
| 43 |
Renewed collaboration aims to improve cancer outcomes in South America
|
Das, Manjulika
|
|
|
25 |
11 |
p. e543
|
artikel
|
| 44 |
Site-specific or empirical chemotherapy for cancer of unknown primary: the right answer?
|
Huey, Ryan
|
|
|
25 |
11 |
p. e529
|
artikel
|
| 45 |
Site-specific or empirical chemotherapy for cancer of unknown primary: the right answer? – Authors' reply
|
Hu, Xichun
|
|
|
25 |
11 |
p. e530
|
artikel
|
| 46 |
Spillover benefits of workforce capacity building in radiotherapy
|
Ngwa, Wilfred
|
|
|
25 |
11 |
p. 1392-1394
|
artikel
|
| 47 |
The Biden administration curbs cancer drug costs for Medicare patients
|
Furlow, Bryant
|
|
|
25 |
11 |
p. 1407
|
artikel
|
| 48 |
The hidden barriers to using cancer registration data
|
Hughes, Nicola
|
|
|
25 |
11 |
p. 1390-1391
|
artikel
|
| 49 |
The state of the science of oral selective oestrogen receptor degraders
|
Fanucci, Kristina
|
|
|
25 |
11 |
p. 1388-1389
|
artikel
|
| 50 |
UK NHS cancer patients to be among those benefiting from deal with life sciences industry
|
Kirby, Tony
|
|
|
25 |
11 |
p. 1406
|
artikel
|
| 51 |
US legislation might soon allow easier access to cancer medications
|
Gruber, Karl
|
|
|
25 |
11 |
p. e544
|
artikel
|
| 52 |
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis
|
Jackson, Ashley
|
|
|
25 |
11 |
p. 1476-1486
|
artikel
|
| 53 |
Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study
|
Ng, Dianna L
|
|
|
25 |
11 |
p. 1440-1452
|
artikel
|
Tijdschrift beschrijving